Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2026-03-22 @ 3:31 PM
Study NCT ID:
NCT04184518
Status:
WITHDRAWN
Last Update Posted:
2020-06-02
First Post:
2019-11-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Durvalumab (MEDI4736) Plus Cediranib in Patients With Metastatic Uveal Melanoma
Sponsor:
Grupo Español Multidisciplinar de Melanoma
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GEM-1805
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |